- funding probability score
- total disclosed funding
- last round valuation estimate
- disclosed funding rounds
- latest round
- latest funding stage
- next round estimate
- development stage
- number of investors
- number of competitors
- monthly web visits
- twitter followers
11335 NE 122nd, Kirkland, 98034, USA
- Aminex Therapeutics, Inc. is focused on bringing its breakthrough discoveries to the clinic to improve the lives of cancer patients. Our small molecule, first-in-class anti-metabolite approach (PBT) should be useful against many hyper-proliferative disease states, yet due to the strong animal efficacy data in hand; it is the strategy of the company to pursue its use for Head and Neck/Squamous Cell Carcinoma (HNSCC) as its first cancer indication. Animex Therapeutics’ recent experiments have demonstrated that PBT has a unique mechanism of action that, when viewed in conjunction with durable cures observed following treatment in animals; give it a clear competitive market advantage.
There is much more to this profile.
Log in or sign up for free to see the whole thing.
Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats